Bimi International Medical Inc (BIMI) - Total Liabilities

Latest as of September 2023: $24.90 Million USD

Based on the latest financial reports, Bimi International Medical Inc (BIMI) has total liabilities worth $24.90 Million USD as of September 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Bimi International Medical Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Bimi International Medical Inc - Total Liabilities Trend (2002–2022)

This chart illustrates how Bimi International Medical Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bimi International Medical Inc total assets.

Bimi International Medical Inc Competitors by Total Liabilities

The table below lists competitors of Bimi International Medical Inc ranked by their total liabilities.

Company Country Total Liabilities
Versarien PLC
LSE:VRS
UK GBX8.28 Million
American Shipping Company ASA
OL:AMSC
Norway Nkr13.00 Million
Eason Technology Limited
NYSE:DXF
USA $42.81 Million
Grand Vision Media Holdings PLC
LSE:GVMH
UK GBX49.70 Million
Seneca Growth Capital VCT PLC
LSE:HYG
UK GBX219.00K
GS Chain PLC
LSE:GSC
UK GBX1.31 Million
Windtree Therapeutics Inc
NASDAQ:WINT
USA $27.58 Million
Captivision Inc
NASDAQ:CAPT
USA $80.62 Million

Liability Composition Analysis (2002–2022)

This chart breaks down Bimi International Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Bimi International Medical Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.86 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.71 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bimi International Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bimi International Medical Inc (2002–2022)

The table below shows the annual total liabilities of Bimi International Medical Inc from 2002 to 2022.

Year Total Liabilities Change
2022-12-31 $30.50 Million +13.83%
2021-12-31 $26.79 Million +64.28%
2020-12-31 $16.31 Million -24.32%
2019-12-31 $21.55 Million +64.93%
2018-12-31 $13.07 Million -7.58%
2017-12-31 $14.14 Million +33.21%
2016-12-31 $10.61 Million -24.07%
2015-12-31 $13.98 Million -17.65%
2014-12-31 $16.97 Million +56.98%
2013-12-31 $10.81 Million -16.95%
2012-12-31 $13.02 Million -8.96%
2011-12-31 $14.30 Million +83.85%
2010-12-31 $7.78 Million +42.65%
2009-12-31 $5.45 Million +117.70%
2008-12-31 $2.50 Million +46.65%
2007-12-31 $1.71 Million +36.43%
2006-12-31 $1.25 Million +95.54%
2005-12-31 $640.17K +18.04%
2004-12-31 $542.33K +71.98%
2003-12-31 $315.35K +74.20%
2002-12-31 $181.03K --

About Bimi International Medical Inc

NASDAQ:BIMI USA Pharmaceutical Retailers
Market Cap
$6.98K
Market Cap Rank
#31846 Global
#6375 in USA
Share Price
$0.00
Change (1 day)
+400.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.03
About

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescr… Read more